{"version":"1.0","provider_name":"UDIBI","provider_url":"https:\/\/udibi.com.mx\/en\/","title":"Biotechnological platforms for the innovation and development of leukemia therapies - UDIBI","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rizmuNqsrV\"><a href=\"https:\/\/udibi.com.mx\/en\/biotechnological-platforms-leukemia\/\">Biotechnological platforms for the innovation and development of leukemia therapies<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/udibi.com.mx\/en\/biotechnological-platforms-leukemia\/embed\/#?secret=rizmuNqsrV\" width=\"600\" height=\"338\" title=\"&#8220;Biotechnological platforms for the innovation and development of leukemia therapies&#8221; &#8212; UDIBI\" data-secret=\"rizmuNqsrV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/udibi.com.mx\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"[vc_row padding_top=&#8221;10&#8243; padding_bottom=&#8221;10&#8243;][vc_column][vc_separator color=&#8221;custom&#8221; accent_color=&#8221;#a1bf3b&#8221;][vc_custom_heading text=&#8221;Biotechnological platforms for the innovation and development of leukemia therapies&#8221; font_container=&#8221;tag:h3|font_size:25|text_align:left|color:%230d1250&#8243; google_fonts=&#8221;font_family:Montserrat%3Aregular%2C700|font_style:700%20bold%20regular%3A700%3Anormal&#8221; css=&#8221;.vc_custom_1644511803116{margin-top: 1px !important;padding-top: 10px !important;}&#8221;][vc_column_text] Acute Lymphoblastic Leukemia (ALL) is a Public Health problem. Since despite the prognosis of childhood leukemia has improved considerably, it is the main cause of death due to disease in children. The current challenge is to develop new [&hellip;]"}